BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23144491)

  • 1. Revising the EU strategy on endocrine disruptors: nearing a decisive moment.
    van Vliet L; Jensen GK
    J Epidemiol Community Health; 2013 May; 67(5):383-4. PubMed ID: 23144491
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocrine disrupters: from research to risk assessment].
    Mantovani A; La Rocca C; Maranghi F
    Epidemiol Prev; 2009; 33(1-2):5-7. PubMed ID: 19585867
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification, assessment and management of "endocrine disruptors" in wildlife in the EU substance legislation--discussion paper from the German Federal Environment Agency (UBA).
    Frische T; Bachmann J; Frein D; Juffernholz T; Kehrer A; Klein A; Maack G; Stock F; Stolzenberg HC; Thierbach C; Walter-Rohde S
    Toxicol Lett; 2013 Dec; 223(3):306-9. PubMed ID: 23500481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collegium Ramazzini statement on the control of pesticides in the European Union: a call for action to protect human health.
    Ramazzini C
    Am J Ind Med; 2009 Feb; 52(2):176-7. PubMed ID: 19016266
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk assessment of adverse environmental factors affecting the health of the Russian population by the Russian State Sanitary and Epidemiological Surveillance].
    Onishchenko GG; Rakhmanin IuA; Tutel'ian VA
    Vopr Pitan; 2003; 72(2):3-7. PubMed ID: 12924201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental health reform in a synthetic world.
    Shah S; Wong S; Bearer C; Brumberg H
    Pediatr Res; 2017 Sep; 82(3):373-375. PubMed ID: 28700570
    [No Abstract]   [Full Text] [Related]  

  • 7. European Union bans atrazine, while the United States negotiates continued use.
    Sass JB; Colangelo A
    Int J Occup Environ Health; 2006; 12(3):260-7. PubMed ID: 16967834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxicological evaluation of crop protection chemicals in the EU registration process].
    Noworyta-Głowacka J; Bańkowski R; Wiadrowska B; Ludwicki JK
    Rocz Panstw Zakl Hig; 2010; 61(1):1-6. PubMed ID: 20803893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endocrine disruptors and metabolic diseases - prevention is essential].
    Benaderette S
    Soins; 2013 Jun; (776):5. PubMed ID: 23878874
    [No Abstract]   [Full Text] [Related]  

  • 10. European Union's strategy on endocrine disrupting chemicals and the current position of Slovenia.
    Perharič L; Fatur T; Drofenik J
    Arh Hig Rada Toksikol; 2016 Jun; 67(2):99-105. PubMed ID: 27331297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing and managing risks arising from exposure to endocrine-active chemicals.
    Phillips KP; Foster WG; Leiss W; Sahni V; Karyakina N; Turner MC; Kacew S; Krewski D
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):351-72. PubMed ID: 18368561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of research on endocrine disruption for the environmental risk assessment, regulation and monitoring of chemicals in the European Union.
    Matthiessen P; Johnson I
    Environ Pollut; 2007 Mar; 146(1):9-18. PubMed ID: 16996184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methods of establishing occupational and environmental hygienic norms].
    Czerczak S; Indulski JA; Kowalski Z; Szymczak W
    Med Pr; 1994; 45(3 Suppl 2):1-88. PubMed ID: 7823802
    [No Abstract]   [Full Text] [Related]  

  • 14. Measuring up: examining the need to establish State-based biomonitoring programs.
    DiSano L
    J Environ Health; 2006 Dec; 69(5):32-3, 38. PubMed ID: 17190340
    [No Abstract]   [Full Text] [Related]  

  • 15. EU regulation of endocrine disruptors: a missed opportunity.
    Kortenkamp A; Bourguignon JP; Slama R; Bergman Å; Demeneix B; Ivell R; Panzica G; Trasande L; Zoeller RT
    Lancet Diabetes Endocrinol; 2016 Aug; 4(8):649-650. PubMed ID: 27377541
    [No Abstract]   [Full Text] [Related]  

  • 16. European union system for the evaluation of substances: the second version.
    Attias L; Boccardi P; Boeije G; Brooke D; de Bruijn J; Comber M; Dolan B; Fischer S; Heinemeyer G; Koch V; Lijzen J; Müller B; Murray-Smith R; Rikken M; Tadeo J; Vermeire T
    Chemosphere; 2005 Apr; 59(4):473-85. PubMed ID: 15788170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whither the impending european regulation of presumed endocrine disruptors?
    Autrup HN; Berry SC; Cohen SM; Creppy EE; de Camargo JL; Dekant W; Dietrich D; Galli CL; Goodman JI; Gori GB; Greim HA; Klaunig JE; Lotti M; Marquardt HW; Wallace KB; Yamazaki H
    Regul Toxicol Pharmacol; 2016 Dec; 82():A1-A2. PubMed ID: 27615676
    [No Abstract]   [Full Text] [Related]  

  • 18. Organic food: panacea for health?
    The Lancet
    Lancet; 2017 Feb; 389(10070):672. PubMed ID: 28229863
    [No Abstract]   [Full Text] [Related]  

  • 19. Deepening uncertainty on how the EU may regulate supposable endocrine disruptors.
    Gori GB; Dekant W
    Regul Toxicol Pharmacol; 2016 Nov; 81():8-9. PubMed ID: 27350054
    [No Abstract]   [Full Text] [Related]  

  • 20. Criteria for Action in Population Health: The Hill Criteria a Half Century Later.
    Rosner D
    Milbank Q; 2015 Jun; 93(2):259-62. PubMed ID: 26044629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.